PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20386083-0	2010	Darunavir/ritonavir and efavirenz exert differential effects on MRP1 transporter expression and function in healthy volunteers.	Darunavir	0-9	CD9 molecule	Homo sapiens	64-68	
20386083-2	2010	We studied MRP1 expression and function in healthy volunteers treated with darunavir/ritonavir and efavirenz.	Darunavir	75-84	CD9 molecule	Homo sapiens	11-15	
20386083-10	2010	MRP1 efflux function was increased after efavirenz administration (GMR 3.13, 95% CI 2.73-3.59; P<0.001) and darunavir/ritonavir plus efavirenz coadministration (GMR 4.35, 95% CI 3.35-5.68; P<0.001), but not after darunavir/ritonavir administration (GMR 1.06, 95% CI 0.80-1.42; P=0.42).	Darunavir	111-120	CD9 molecule	Homo sapiens	0-4	
20386083-10	2010	MRP1 efflux function was increased after efavirenz administration (GMR 3.13, 95% CI 2.73-3.59; P<0.001) and darunavir/ritonavir plus efavirenz coadministration (GMR 4.35, 95% CI 3.35-5.68; P<0.001), but not after darunavir/ritonavir administration (GMR 1.06, 95% CI 0.80-1.42; P=0.42).	Darunavir	219-228	CD9 molecule	Homo sapiens	0-4	
20386083-11	2010	CONCLUSIONS: Darunavir/ritonavir and efavirenz treatment exerted differential effects on MRP1 expression and function.	Darunavir	13-22	CD9 molecule	Homo sapiens	89-93